Τόμος 20 (2006) – Τεύχος 2 – Άρθρο 90 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 20 (2006) – Issue 2 – Article 90 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Phosphorylation of DARPP-32 (dopamine and cAMP regulated phosphoprotein of 32 KDa) induced by in vivo stimulation of adenosine A2A receptors in striatum of the dopamine-depleted weaver mouse
Author O. Pavlou¹, P. Poulou², A. Ekonomou²,³ and F. Angelatou²

1. Dept of Materials Science, School of Natural Sciences and 2. Dept. of Physiology, Medical School, University of Patras, Greece

3. Stem Cell Biology Lab., Wolfson Center, King’s College, London, UK

Citation Pavlou, O., Pavlou, P., Ekonomou, A., Angelatou, F.: Phosphorylation of DARPP-32 (dopamine and cAMP regulated phosphoprotein of 32 KDa) induced by in vivo stimulation of adenosine A2A receptors in striatum of the dopamine-depleted weaver mouse, Epitheorese Klin. Farmakol. Farmakokinet. 20(2): 298-300 (2006)
Publication Date Accepted for publication: 19-20 May 2006
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Weaver mutant, dopamine deficiency, A2A receptors, DARPP-32.
Other Terms review article
Summary Adenosine modulates neurotransmission in the basal ganglia acting via its A2A receptors. These are co-localized and interact functionally with D2 receptors, on the indirect pathway’s medium sized spiny neurons of the striatum, exerting opposing actions on neurotransmitter release, gene expression, and motor behavior. A recent study in our laboratory has shown that in vivo activation of adenosine A2A receptors elicits a strong expression of the immediate early gene (IEG) zif/268 in striatum and motor cortex of the weaver mouse, a genetic model of dopamine deficiency. In the present study, in order to clarify the signal transduction pathway mediating zif/268 induction via A2A adenosine receptors, we examined the phosphorylation state of DARPP-32 in striatal membranes of the weaver mouse after a single injection of CGS21680 (an A2A receptor agonist). DARPP-32 is a potent endogenous inhibitor of protein-phosphatase-1 (PP-1), which plays an obligatory role in dopaminergic transmission. Preliminary results demonstrated a significant upregulation of the phosphorylation levels of DARPP-32 in striatum of the weaver but not of the control mice. The phosphorylation levels of DARPP-32 were examined using Western blot analysis using a specific antibody directed against the phospho-Thr-34 moiety. These results indicate a super- sensitivity of A2A adenosine receptors, which under dopamine deficiency potentiate signaling, probably by activation of the A2A/cAMP/PKA/DARPP-32/PP-1 signal transduction pathway. We also investigate the pathways that lead to the IEG induction by examining the possible activation of other regulators, such as Mitogen Activated Protein Kinases.
References 1. Ekonomou et al.: Neuroscience 123: 1025 (2004)

2. Greengard et al.: Neuron 23: 435 (1999)

3. Svennigsson et al.: PNAS 97: 1856 (2000)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2006 – ANNUAL SUBSCRIPTION 2006
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

 

Bookmark the permalink.

Comments are closed.